These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29132653)

  • 21. Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: a (1)H MRS study at 3Tesla.
    Crocker CE; Bernier DC; Hanstock CC; Lakusta B; Purdon SE; Seres P; Tibbo PG
    Schizophr Res; 2014 Aug; 157(1-3):231-7. PubMed ID: 24906219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings.
    Marenco S; Meyer C; Kuo S; van der Veen JW; Shen J; DeJong K; Barnett AS; Apud JA; Dickinson D; Weinberger DR; Berman KF
    Am J Psychiatry; 2016 May; 173(5):527-34. PubMed ID: 26806873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals.
    León-Ortiz P; Rivera-Chávez LF; Torres-Ruíz J; Reyes-Madrigal F; Carrillo-Vázquez D; Moncada-Habib T; Cassiano-Quezada F; Cadenhead KS; Gómez-Martín D; de la Fuente-Sandoval C
    Brain Behav Immun; 2023 Jul; 111():270-276. PubMed ID: 37149107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low single dose gabapentin does not affect prefrontal and occipital gamma-aminobutyric acid concentrations.
    Preuss N; van der Veen JW; Carlson PJ; Shen J; Hasler G
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1708-13. PubMed ID: 24071367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naïve patients with first-episode psychosis.
    Ota VK; Noto C; Gadelha A; Santoro ML; Ortiz BB; Andrade EH; Tasso BC; Spindola LM; Silva PN; Abílio VC; Smith Mde A; Sato JR; Brietzke E; Cordeiro Q; Bressan RA; Belangero SI
    J Psychiatr Res; 2014 Sep; 56():130-6. PubMed ID: 24935901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.
    Gan JL; Cheng ZX; Duan HF; Yang JM; Zhu XQ; Gao CY
    Psychiatry Res; 2014 Jul; 223(1):23-7. PubMed ID: 24831926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
    Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
    Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
    Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
    Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients.
    Reyes-Madrigal F; Guma E; León-Ortiz P; Gómez-Cruz G; Mora-Durán R; Graff-Guerrero A; Kegeles LS; Chakravarty MM; de la Fuente-Sandoval C
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110473. PubMed ID: 34748864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.
    Modinos G; Şimşek F; Azis M; Bossong M; Bonoldi I; Samson C; Quinn B; Perez J; Broome MR; Zelaya F; Lythgoe DJ; Howes OD; Stone JM; Grace AA; Allen P; McGuire P
    Neuropsychopharmacology; 2018 Dec; 43(13):2652-2659. PubMed ID: 29440719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis.
    Ota VK; Noto C; Santoro ML; Spindola LM; Gouvea ES; Carvalho CM; Santos CM; Xavier G; Higuchi CH; Yonamine C; Moretti PN; Abílio VC; Hayashi MA; Brietzke E; Gadelha A; Cordeiro Q; Bressan RA; Belangero SI
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2416-25. PubMed ID: 26476704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.
    Egerton A; Griffiths K; Casetta C; Deakin B; Drake R; Howes OD; Kassoumeri L; Khan S; Lankshear S; Lees J; Lewis S; Mikulskaya E; Millgate E; Oloyede E; Pollard R; Rich N; Segev A; Sendt KV; MacCabe JH
    Neuropsychopharmacology; 2023 Feb; 48(3):567-575. PubMed ID: 36456813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.
    Chua SE; Deng Y; Chen EY; Law CW; Chiu CP; Cheung C; Wong JC; Lienenkaëmper N; Cheung V; Suckling J; McAlonan GM
    Psychol Med; 2009 May; 39(5):793-800. PubMed ID: 18713487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute stress effects on GABA and glutamate levels in the prefrontal cortex: A 7T
    Houtepen LC; Schür RR; Wijnen JP; Boer VO; Boks MP; Kahn RS; Joëls M; Klomp DW; Vinkers CH
    Neuroimage Clin; 2017; 14():195-200. PubMed ID: 28180078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
    Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.
    Kindler J; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Walther S; Schimmelmann BG; Hubl D
    Schizophr Bull; 2018 Jan; 44(1):182-192. PubMed ID: 28575528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.
    Bojesen KB; Broberg BV; Fagerlund B; Jessen K; Thomas MB; Sigvard A; Tangmose K; Nielsen MØ; Andersen GS; Larsson HBW; Edden RAE; Rostrup E; Glenthøj BY
    Biol Psychiatry; 2021 Feb; 89(3):278-287. PubMed ID: 32928500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.